- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
38 result(s) found for: Antimicrobial Resistance.
Displaying page 1 of 2.
EudraCT Number: 2016-004447-36 | Sponsor Protocol Number: ZonMw848015005 | Start Date*: 2017-06-23 |
Sponsor Name:Stichting Rotterdams Onderzoeksconsortium Kindergeneeskunde | ||
Full Title: INTRAVENOUS-TO-ORAL ANTIBIOTIC SWITCH THERAPY FOR SUSPECTED NEONATAL BACTERIAL INFECTIONS: CLINICAL EFFICACY, SAFETY AND COST-EFFECTIVENESS | ||
Medical condition: Neonatal probable bacterial infection | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003321-29 | Sponsor Protocol Number: 17-169 | Start Date*: Information not available in EudraCT |
Sponsor Name:RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty | ||
Full Title: Clinical relevance of the antimicrobial resistance testing in the treatment of chronic wounds with antiseptics | ||
Medical condition: Decubitus, acute or chronic wounds (open wounds existing ≥ 14 days) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-004333-42 | Sponsor Protocol Number: SISPCT | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Friedrich-Schiller-University of Jena | |||||||||||||
Full Title: Prospective randomized clinical multicenter trial about the effect of an adjunctive intravenous treatment with sodium selenite (selenase®T, double-blind) and a procalcitonin guided causal therapy (... | |||||||||||||
Medical condition: severe sepsis / septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000036-41 | Sponsor Protocol Number: IPTG-01 | Start Date*: 2014-04-08 | |||||||||||
Sponsor Name:Dermal Laboratories Ltd | |||||||||||||
Full Title: An antimicrobial cream for the treatment of impetigo | |||||||||||||
Medical condition: The condition to be studied is uncomplicated localised primary non-bullous impetigo, suitable for topical antibacterial therapy alone. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004211-30 | Sponsor Protocol Number: 2005-23 | Start Date*: 2005-10-17 |
Sponsor Name:The Norwegian Radium Hospital | ||
Full Title: Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia | ||
Medical condition: Lymphoma and leukemia patients with febrile neutropenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001313-15 | Sponsor Protocol Number: 555555 | Start Date*: 2006-06-20 |
Sponsor Name:University of Dundee | ||
Full Title: Cranberry product versus low dose trimethoprim in the prevention of recurrent urinary infections in older women: a double blind randomised trial of effectiveness and acceptability | ||
Medical condition: Recurrent urinary tract infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003931-30 | Sponsor Protocol Number: CBS-EAM-10d | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Hôpital Universitaire Des Enfants Reine Fabiola | |||||||||||||
Full Title: A prospective open-label study on efficacy and tolerability of colloidal bismuth sub-citrate as adjunctive therapy to a combination of esomeprazole, amoxicillin and metronidazole for 10 days for He... | |||||||||||||
Medical condition: Helicobacter pylory infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000741-39 | Sponsor Protocol Number: 6996 | Start Date*: 2019-11-07 |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: EFFECT OF AZITHROMYCIN ON THE PROPORTION OF FAILURES OF SEVERE PERIODONTITIS NON-SURGICAL TREATMENTS : A RANDOMIZED, DOUBLE-BLIND VERSUS PLACEBO STUDY | ||
Medical condition: Periodontology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000450-21 | Sponsor Protocol Number: MONS4STRAT | Start Date*: 2018-04-09 |
Sponsor Name:Fundación Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Prospective, Randomized, Open, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of the MON4STRAT Approach for Optimizing Meropenem Therapy in Intubated and Mechanically-Ventilated,... | ||
Medical condition: Nosocomial pneumonia or severe tracheobronchitis caused by Gram-negative pathogens in subjects that requiring mechanical ventilation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001396-16 | Sponsor Protocol Number: OP0595-6 | Start Date*: 2023-07-07 | |||||||||||||||||||||||||||||||
Sponsor Name:Meiji Seika Pharma Co., Ltd. | |||||||||||||||||||||||||||||||||
Full Title: A Phase 3, Multi-Center, Randomized, Single-Blind Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complicated Ur... | |||||||||||||||||||||||||||||||||
Medical condition: Complicated urinary tract infection (cUTI), acute uncomplicated pyelonephritis (AP), hospital acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), and complicated ... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: SK (Ongoing) GR (Ongoing) ES (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001048-73 | Sponsor Protocol Number: BAY41-6551/13084 | Start Date*: 2013-07-25 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Pati... | |||||||||||||
Medical condition: Gram-negative pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000581-38 | Sponsor Protocol Number: 17/0894 | Start Date*: 2019-07-29 | |||||||||||
Sponsor Name:University College London Comprehensive Clinical Trials Unit | |||||||||||||
Full Title: ASEPTIC: Primary Antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis | |||||||||||||
Medical condition: Spontaneous bacterial peritonitis infection in patients with advanced liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004677-14 | Sponsor Protocol Number: DIABOLO | Start Date*: 2018-03-09 |
Sponsor Name:Erasmus MC | ||
Full Title: Dose IndividualizAtion of Beta-lactam and fluOroquinoLone AntiBiotics in ICU patients: to TDM or not to TDM and the effects on Outcome (DIABOLO-study) | ||
Medical condition: ICU patients with infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001257-14 | Sponsor Protocol Number: P160910J | Start Date*: 2018-04-13 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Temocillin versus a carbapenem as initial intravenous treatment for extended-spectrum beta-lactamase related urinary tract infections, a non-inferiority study.TEMO-CARB | |||||||||||||
Medical condition: -Hospitalized patient with complicated UTI due to ESBL producing enterobacteriaceae (pyelonephritis, prostatitis or renal abscess) requiring parenteral antimicrobial therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000332-34 | Sponsor Protocol Number: NL-07051985 | Start Date*: 2017-08-23 | |||||||||||
Sponsor Name:Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht | |||||||||||||
Full Title: Topical or oral antibiotics for children with acute otitis media presenting with ear discharge? | |||||||||||||
Medical condition: Acute otitis media with ear discharge | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001441-12 | Sponsor Protocol Number: OP0595-5 | Start Date*: 2023-03-10 | ||||||||||||||||
Sponsor Name:Meiji Seika Pharma Co., Ltd. | ||||||||||||||||||
Full Title: A Phase 3, Multi-Center, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of Compli... | ||||||||||||||||||
Medical condition: Complicated urinary tract infection (cUTI) and acute uncomplicated pyelonephritis (AP) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: LT (Ongoing) BG (Ongoing) SK (Ongoing) CZ (Ongoing) LV (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002528-17 | Sponsor Protocol Number: AC-061A301 | Start Date*: 2014-03-14 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: A multi-center, randomized, double-blind study to compare the efficacy and safety of cadazolid versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD) | |||||||||||||
Medical condition: Clostridium difficile-associated diarrhea (CDAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) ES (Completed) PL (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000990-22 | Sponsor Protocol Number: STI_Zoli001 | Start Date*: Information not available in EudraCT |
Sponsor Name:GARDP FOUNDATION | ||
Full Title: A MULTI-CENTER, RANDOMIZED, OPEN-LABEL, NON INFERIORITY TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE, ORAL DOSE OF ZOLIFLODACIN COMPARED TO A COMBINATION OF A SINGLE INTRAMUSCULAR DOSE OF ... | ||
Medical condition: Uncomplicated gonorrhoea | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002938-23 | Sponsor Protocol Number: pro-SWAP104622 | Start Date*: 2018-02-06 | |||||||||||||||||||||
Sponsor Name:Radboud University Medical Center | |||||||||||||||||||||||
Full Title: The effect of rectal swab culture-guided antimicrobial prophylaxis in men undergoing prostate biopsy on infectious complications and cost of care: A randomized controlled trial in the Netherlands. | |||||||||||||||||||||||
Medical condition: Antimicrobial prophylaxis for patients undergoing prostate biopsy concerning infectious complications. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002508-15 | Sponsor Protocol Number: AC-061A302 | Start Date*: 2014-03-03 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: A multi-center, randomized, double-blind study to compare the efficacy and safety of cadazolid versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD) | |||||||||||||
Medical condition: Clostridium difficile-associated diarrhea (CDAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) HU (Completed) SK (Completed) GR (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.